Some aspects of the development and correction of secondary exocrine insufficiency of the pancreas in children


  • M.I. Kinash I. Horbachevsky Ternopil National Medical University, Ukraine


Based on the analysis of literature sources, the main causes and mechanisms of the secondary exocrine pancreatic insufficiency in children are highlighted. The main mechanisms of regulation and peculiarities of functional activity of the pancreas in children are discussed. The importance of pancreatic enzymes for physiological digestion of food nutrients as well as for ensuring satisfactory nutritional status of a child is noted. It is shown that the main reason for the development of secondary exocrine insufficiency of the pancreas in children is a violation of the pancreatic enzymes activity in the duodenum. Factors that adversely affect the effectiveness of pancreatic enzymes by disrupting their activation or inactivation in the duodenum have been listed. They include: 1) motility disorders of the gastrointestinal tract; 2) bile acid deficiency; 3) violation of entero-pancreatic regulation of the pancreas; 4) hyperacidic conditions of the stomach and duodenum; 5) intestinal dysbacteriosis; 6) violation of the outflow of pancreatic juice into the duodenum. The mechanisms of negative influence of these factors on the activity of pancreatic enzymes are also revealed. It is noted that the increase in the prevalence of secondary exocrine pancreatic insufficiency is due to the peculiarities of diseases of the digestive system, namely, the combined nature of the lesions of different parts of the gastrointestinal tract. The effective properties of the mini-tablet enzyme preparation, as well as indications for its use are analyzed; the dosage of enzyme preparations for children in accordance with domestic and foreign recommendations was discussed. The list of pathological conditions in which it is advisable to use enzyme preparations, as well as the requirements that must be met when using enzyme preparations to achieve maximum effectiveness during enzyme replacement therapy.



Abu-El-Haija M, Kumar S, Quiros JA et al. (2018). Management of Acute Pancreatitis in the Pediatric Population: A Clinical Report from the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition Pancreas Committee. J Pediatr Gastroenterol Nutr. 66 (1): 159-176.; PMid:29280782 PMCid:PMC5755713

Berry AJ. (2014). Pancreatic enzyme replacement therapy during pancreatic insufficiency. Nutr Clin Pract. 29 (3): 312-321.; PMid:24687867

Byelousova OYu, Solodovnychenko IH. (2020). Formuvannia y optymalna korektsiia zovnishnosekretornoi pankreatychnoi nedostatnosti u ditej. Hastroenterolohiia. Hepatolohiia. Koloproktolohiia. 1 (55): 3-4.

Conwell DL, Lee LS, Yadav D et al. (2014). American pancreatic association practice guidelines in chronic pancreatitis: evidence-based report on diagnostic guidelines. Pancreas. 43: 1143-1162.; PMid:25333398 PMCid:PMC5434978

De-Madaria E, Abad-Gonzalez A, Aparicio JR et al. (2013). The Spanish Pancreatic Club's recommendations for the diagnosis and treatment of chronic pancreatitis: part 2 (treatment). Pancreatology. 13: 18-28.; PMid:23395565

Duggan SN. (2017). Negotiating the complexities of exocrine and endocrine dysfunction in chronic pancreatitis. Proc Nutr Soc. 76 (4): 484-494. Epub 2017 Jul 24.; PMid:28735575

Durie PR. (2000). Pancreatic aspects of cystic fibrosis and other inherited causes of pancreatic dysfunction. Med Clin North Am. 84 (3): 609-620. PMID:10872418.

Fieker A, Philpott J, Armand M. (2011). Enzyme replacement therapy for pancreatic insufficiency: present and future. Clin Exp Gastroenterol. 4: 55-73.; PMid:21753892 PMCid:PMC3132852

Frulloni L, Falconi M, Gabbrielli A et al. (2010). Italian consensus guidelines for chronic pancreatitis. Dig Liver Dis. 42 (6): 381-406. PMID: 21078490.

Ghodeif AO, Azer SA. (2020). Pancreatic Insufficiency. In: StatPearls. Treasure Island (FL): StatPearls Publishing. PMID: 32310386.

Gubergric NB. (2003). Etiologiya, patogenez, klinika i lechenie ekzokrinnoj pankreaticheskoj nedostatochnosti. Mystetstvo likuvannia. 2: 27-32.

Hoffmeister A, Mayerle J, Beglinger C et al. (2015). English language version of the S3-consensus guidelines on chronic pancreatitis: definition, aetiology, diagnostic examinations, medical, endoscopic and surgical management of chronic pancreatitis. Z Gastroenterol. 53: 1447-1495.; PMid:26666283

Horlenko OM, Kossei HB, Roshko IH et al. (2013). Vtorynna pankreatychna nedostatnist u ditej, shliakhy korektsii. Problemy klinichnoi pediatrii. 2 (20): 78-81.

Keller J, Aghdassi AA, Lerch MM et al. (2009). Tests of pancreatic exocrine function - clinical significance in pancreatic and non-pancreatic disorders. Best Pr Res Clin Gastroenterol. 23 (3): 425-439.; PMid:19505669

Khavkin AI. (2012). Otnositel'naya e'kzokrinnaya nedostatochnost' podzheludochnoj zhelezy' u detej. Voprosy sovremennoj pediatrii. 11 (3): 108-111.

Kinash MI, Kabakova AB. (2009). Efektyvnist zastosuvannia «Panhrolu» u ditej z ekzokrynnoiu nedostatnistiu pidshlunkovoi zalozy. Sovremennaya pediatriya. 2: 147-151.

Kumar S, Ooi CY, Werlin S et al. (2016). Risk Factors associated with pediatric acute recurrent and chronic pancreatitis: Lessons from INSP-PIRE. JAMA Pediatr. 1. 170 (6): 562-569.; PMid:27064572 PMCid:PMC5317277

Louie DS, May D, Miller P, Owyang C. (1986). Cholecystokinin mediates feedback regulation of pancreatic enzyme secretion in rats. Am J Physiol. 250 (2, 1): G252-259.; PMid:3953805

Marushko YuV, Hyshchak TV. (2009). Fermentni preparaty dlia korektsii ekzokrynnoi pankreatychnoi nedostatnosti u pediatrychnii praktytsi. Sovremennaya pediatriya. 6 (28): 118-122.

Perez EA, Gutierrez JC, Koniaris LG et al. (2009). Malignant pancreatic tumors: incidence and outcome in 58 pediatric patients. J Pediatr Surg. 44 (1): 197-203.; PMid:19159743

Pongprasobchai S. (2013). Maldigestion from pancreatic exocrine insufficiency. J Gastroenterol Hepatol. 28 (4): 99-102.; PMid:24251713

Rimarchuk GV, Tyurina TK. (2008). Osobennosti diagnostiki i terapevticheskoj taktiki pri hronicheskih pankreatitah u detej. Rossijskij vestnik perinatologii i pediatrii. 53 (3): 61-67.

Sankararaman S, Schindler T, Sferra TJ. (2019). Management of Exocrine Pancreatic Insufficiency in Children. Nutr Clin Pract. 34 (1): S27-S42.; PMid:31535732

Shevchuk VH ta in. (2018). Fiziolohiia. Vinnytsia: Nova knyha: 448.

Smith RC, Smith SF et al. (2016). Working Party of the Australasian Pancreatic Club, Summary and recommendations from the Australasian guidelines for the management of pancreatic exocrine insufficiency. Pancreatology. 16: 164-180.; PMid:26775768

Taylor CJ, Chen K, Horvath K et al. (2015). ESPGHAN and NASPGHAN report on the assessment of exocrine pancreatic function and pancreatitis in children. J Pediatr Gastroenterol Nutr. 61 (1): 144-153.; PMid:25915425

Trout AT, Wallihan DB, Serai S, Abu-El-Haija M. (2017). Secretinenhanced magnetic resonance cholangiopancreatography for assessing pancreatic secretory function in children. J Pediatr. 188: 186-191.; PMid:28693787

Vujasinovic M, Valente R, Thorell A et al. (2017). Pancreatic exocrine insufficiency after bariatric surgery. Nutrients. 9 (11): 1241.; PMid:29137169 PMCid:PMC5707713